首页> 外文OA文献 >T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2

【2h】

T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2

机译：T-DM1是一种新型抗体 - 药物缀合物，对患有过表达HER2的子宫和卵巢癌肉瘤非常有效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Roberta Nicoletti; Salvatore Lopez; Stefania Bellone; Emiliano Cocco; Carlton L. Schwab; Jonathan D. Black; Floriana Centritto; Liancheng Zhu; Elena Bonazzoli; Natalia Buza; Pei Hui; Delia Mezzanzanica; Silvana Canevari; Peter E. Schwartz; Thomas J. Rutherford; Alessandro D. Santin;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2 [J] . Nicoletti Roberta, Lopez Salvatore, Bellone Stefania, Clinical and experimental metastasis . 2015,第1期

机译：T-DM1，一种新型抗体-药物结合物，对过度表达HER2的子宫和卵巢癌肉瘤非常有效
2. T‐DM1, a novel antibody–drug conjugate, is highly effective against primary HER2 overexpressing uterine serous carcinoma in vitro and in vivo [J] . Carlton L. Schwab, Dan-Arin Silasi, Diana P. English, Cancer Medicine . 2014,第5期

机译：T-DM1，一种新型的抗体-药物结合物，在体外和体内对原发性HER2过表达的子宫浆液性癌都有很高的疗效
3. DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance [J] . Takegawa Naoki, Nonagase Yoshikane, Yonesaka Kimio, International Journal of Cancer =: Journal International du Cancer . 2017,第8期

机译：DS-8201A，一种掺入新型DNA拓扑异构酶I抑制剂的新的HER2靶向抗体 - 药物缀合物，克服了HER2阳性胃癌T-DM1抗性
4. Whole-body imaging of HER2eu-overexpressing tumors using scFv-antibody conjugated quantum dots [C] . Irina V. Balalaeva, Tatyana A. Zdobnova, Anna A. Brilkina, Colloidal quantum dots for biomedical applications V . 2010

机译：使用scFv抗体偶联的量子点对HER2 / neu过表达的肿瘤进行全身成像
5. Analysis of the Efficacy and Cytotoxicity of a Synthesized Anti-HER2 Antibody-drug Conjugate [D] . Blackburn, Brody. 2020

机译：分析合成抗HER2抗体 - 药物缀合物的疗效和细胞毒性
6. T-DM1 a novel antibody-drug conjugate is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2 [O] . Roberta Nicoletti, Salvatore Lopez, Stefania Bellone, -1

机译：T-DM1一种新型抗体-药物结合物对过度表达HER2的子宫和卵巢癌肉瘤非常有效
7. SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody–Drug Conjugate, Shows Antitumor Activity in Uterine and Ovarian Carcinosarcoma with HER2/Neu Expression [O] . Gulden Menderes, Elena Bonazzoli, Stefania Bellone, 2017

机译：SYD985是一种基于新的Duocarmycin的HER2靶向抗体 - 药物缀合物，显示出在子宫和卵巢癌的抗肿瘤活性与HER2 / NEU表达

T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2

著录项

相似文献

相关主题

期刊订阅